Want to Subscribe?
Read Corporate India and add to your Business Intelligence

Unlock Unlimited Access
Editorial 123 15
Having lost around Rs 147,600 crore ($ 18 billion) in the IPO market during 2022, the investing public is now ultra-suspicious of the new issue market, unscrupulous promoters and their greedy advisers in the form of merchant bankers. But the promoter-merchant banker combine — fearing that its honeypot, the Indian IPO market, will lose steam during 2023 — continues to paint the mirage of overnight riches for innocent investors who are naturally lured by this prospect. And despite the harsh reality of post-IPO plunges in stock values, the game of luring investors with the hype of making them wealthy overnight through subscription to high-priced IPOs continues unabated.
Investors have been duped by the hype created over technology issues like PayTM, Zomato, AGS Transport Tech and Rainbow Chidren’s Medicine, as well as by Life Insurance Corporation, Ethos, Prudent Corporate Advices, Uma Exports, Nykaa and Cartrade. Post IPOs, these stocks have sent shivers down the spines of investors as most of these exorbitantly priced scrips have lost value substantially, either immediately after getting listed or after some time.
With the investing public losing a humongous amount of around Rs 147,600 crore, they are in no mood to listen to the pied pipers in the form of merchant bankers. But the unscrupulous promoter-merchant banker combine is not giving up and is doing its best to bring disgruntled investors back to the market.
In fact, promoters and merchant bankers are getting ready to ‘present’ over 50 IPOs in the new year. These may include Droom Technology, Snapdeal Ltd, TBO Tech, Capillary Technologies, Protein eGov Technologies, Letravenues Technologies, Asianet Satellites Communications, CMR Green Technologies and Oravel Stays (OYO). In fact, the hype over these issues is already being propagated by merchant bankers.
The crux of the issue is the exorbitant pricing that these promoters and their merchant bankers decide for IPOs. In this connection, one fails to understand why market regulator SEBI is not focusing on its core obligation of regulating the functioning of the capital market and protecting the interests of the investing pubiic. While SEBI continues to tinker with IPO rules and regulations, it has paid scant attention to the major problem of the uncalled-for exhorbitant pricing of IPOs. On the contrary, it seems to have given a free hand to promoters and merchant bankers whose primary target is the innocent retail investor.
Contrastingly, the new issue pricing policy adopted by the Controller of Capital Issues in an earlier era had gone a long way in spreading the equity cult far and wide. Ironically, the working of its successor, SEBI, is proving to be detrimental to both the investing public and the health of the equity cult in the country.
If one compares the prices fixed by the CCI of several multinational companies in the days when the latter were asked to dilute their foreign holding with the prices being charged by our promoter-merchant banker combine of say PayTM, Reliance power, Life Insurance Corporation, Uma Exports, Zomato, AGS Transport Tech, Fino Payments Bank, one will be shocked that these ordinary companies have priced their stock at a much higher level than even giant multinational companies. It is intriguing that SEBI remains a silent spectator to such a 'tamasha'. Today's merchant bankers should be congratulated for their ability to palm off shares of even loss-making companies at prices higher than those of multi-bagger multinationals! The time has come for SEBI to develop a mechanism to regulate IPO pricing policy to prevent promoter-merchant banker combine to openly loot the hapless investors.
Cover story 123 15
Happy days are back for the Indian banking sector, especially big banks, mainly as the bad dream of mounting NPAs has been dispelled by the government recapitalizing banks and creating a ‘bad bank’ to take the NPA burden off their backs. The other factor boosting the banking sector’s financials is the sharp recovery in credit demand and the raising of interest rates by the Reserve Bank.
Corporate Development 123 15
Marksans Pharma (MPL), engaged in manufacturing and marketing generic pharmaceutical formulations and with a strong global footprint, has continued its growth momentum in Q2. On a consolidated y-o-y basis, operating revenues at Rs 452.6 crore are higher by 25.5% from Rs 361.2 crore whereas EBITDA has impressively improved from Rs 60.1 crore to Rs 80.3 crore, exhibiting an increase of 110 bps from 16.6% to 17.7%. Net profit saw a 30% jump from Rs 46.3 crore to Rs 60.1 crore, translating into EPS of Rs 1.52 against Rs 1.11 on its one-rupee face value.
Fortune Scrip
Polycab India Limited (PIL), a leading electrical brand with over Rs 122 billion in revenues, is the largest manufacturer of wires and cables in India and at the same time one of the fastest growing players in the FMEG (Fast Moving Electrical Goods) space. This fortnight, we have selected this company as the Fortune Scrip as it has tremendous growth prospects going ahead.
Corporate Feature 123 15
The Gurugram-headquartered start-up is winning over scores of clients with its thrust on trust and transparency, and providing value-added services to clients. Not surprisingly, it is the go-to company for people looking to buy and sell property, whether residential or commercial, with total accountability and transparency. Be it residential or commercial property, or land, at any promising location, Neudoor guides its clients on all aspects of a deal. According to its founding trio Priyank Sahni, Amit Chawla and Ankur Luthra, the company ensures that sellers get outstandingly competent clientele and that buyers get access to the best properties and agents.
Share X-Ray 123 15
Incorporated in 1973, Dynamatic Technologies (DTL) – a Bangalore-headquartered NSE-BSE listed company — is primarily engaged in design and building of highly engineered products broadly attributed to automotive, aeronautic, hydraulic and security applications.
February 15, 2025 - First Issue
Industry Review
Want to Subscribe?
Read Corporate India and add to your Business Intelligence
Unlock Unlimited Access
Lighter Vein
Popular Stories
Archives